Health Care Technology

Auriga has published a report on Computer Programs & Systems Inc. (NASDAQ: CPSI) raising the price target to $78. In the report, Auriga wrote, "We are maintaining our HOLD rating on CPSI (CPSI), raising our price target to $78 (from $60 ) while crediting the company with outstanding Q2...

Goldman Sachs is out with its report today on Computer Programs & Systems (NASDAQ: CPSI), raising its PT from $81 to $87. In its report, Goldman Sachs writes, "We increase our 12-month price target to $87 from $81 — on a weighted average of our 2012 EV/EBITDA, DCF, and M&A analyses. Our...

Auriga has raised the price target on Computer Programs & Systems (NASDAQ: CPSI) from $60 to $78 and maintains its Hold rating.

Goldman Sachs has raised the price target on Computer Programs & Systems (NASDAQ: CPSI) from $81 to $87 and maintains its Buy rating.

Stocks trading at or near 52-week highs and lows provide excellent trading opportunities, as volatility tends to increase at such levels and exit/entry points become more clearly defined. The following stocks hit new 52-week highs in Friday's trading session (listed from highest total volume to...

J.P. Morgan is out with its report today on Cerner (NASDAQ: CERN), raising its PT from $60 to $76. In its report, J.P. Morgan writes, "Cerner reported another outstanding bookings quarter yesterday, with bookings up 39% y/y to $650M, $85M ahead of our estimate. EPS beat by $0.01 to come in at $0....

Auriga has raised the price target on Cerner (NASDAQ: CERN) from $65 to $72 and maintains its Buy rating.

This is your Benzinga news summary and traders' outlook for Friday, July 29, 2011, covering headlines from overnight and Friday's pre-market session. Today in domestic pre-market trading, U.S. equity futures are trading lower as traders worry about when the decision on the debt ceiling will be...

JP Morgan has raised the price target on Cerner (NASDAQ: CERN) from $60 to $76 and maintains its Overweight rating.

Piper Jaffray has raised the price target on Cerner Corporation (NASDAQ: CERN) from $64.50 to $70 and maintains its Overweight rating.

iCAD, Inc. (Nasdaq: ICAD) today announced the installation of two veterinary Xoft Axxent® eBx™ electronic brachytherapy systems at veterinary clinics in Rhode Island and New York. The two systems were recently placed as the result of an exclusive agreement established last year with Sound-Eklin™, a...

According to Piper Jaffray, Omnicell (NASDAQ: OMCL), PT and FY12 EPS estimates are revised. Piper Jaffray increased the PT of Omnicell from $17 to $19 and FY12 EPS estimates from $0.69 to $0.71. The stock is currently rated as Overweight. Omnicell closed yesterday at $16.46.

Duncan Williams reiterated its Hold rating on Computer Program and Systems (NASDAQ: CPSI). At the moment, the rating agency does not have a price target placed on the company's stock. On Tuesday, CPSI closed the day at $61.01.

Piper Jaffray has raised the price target on Omnicell (NASDAQ: OMCL) from $17 to $19 and maintains its Overweight rating.

This is your Benzinga news summary and traders' outlook for Tuesday, July 26, 2011, covering headlines from overnight and Tuesday's pre-market session. Today in domestic pre-market trading, U.S. equity futures are trading higher after strong earnings from several blue-chip companies. The U.S....